Department of Radiology, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
Cardiovasc Intervent Radiol. 2011 Apr;34(2):319-30. doi: 10.1007/s00270-010-9926-7. Epub 2010 Jun 29.
The current study retrospectively evaluated whether endovascular revascularization of chronically thrombosed and long-discarded vascular access sites for hemodialysis was feasible. Technical and clinical success rates, postintervention primary and secondary patency rates, and complications were reported. During a 1-year period, we reviewed a total of 924 interventions performed for dysfunction and/or failed hemodialysis vascular access sites and permanent catheters in 881 patients. In patients whose vascular access-site problems were considered untreatable or were considered treatable with a high risk of failure and access-site abandonment, we attempted to revascularize (resurrect) the chronically occluded and long-discarded (mummy) vascular access sites. We attempted to resurrect a total of 18 mummy access sites (mean age 46.6 ± 38.7 months; range 5-144) in 15 patients (8 women and 7 men; mean age 66.2 ± 11.5 years; age range 50-85) and had an overall technical success rate of 77.8%. Resurrection failure occurred in 3 fistulas and in 1 straight graft. The clinical success rate was 100% at 2 months after resurrection. In the 14 resurrected vascular access sites, 6 balloon-assisted maturation procedures were required in 5 fistulas; after access-site maturation, a total of 22 interventions were performed to maintain access-site patency. The mean go-through time for successful resurrection procedures was 146.6 ± 34.3 min (range 74-193). Postmaturation primary patency rates were 71.4 ± 12.1% at 30 days, 57.1 ± 13.2% at 60 days, 28.6 ± 13.4% at 90 days, and 19 ± 11.8% at 180 days. Postmaturation secondary patency rates were 100% at 30, 60, and 90 days and 81.8 ± 11.6% at 180 days. There were 2 major complications consisting of massive venous ruptures in 2 mummy access sites during balloon dilation; in both cases, prolonged balloon inflation failed to achieve hemostasis, but percutaneous N-butyl cyanoacrylate glue seal-off was performed successfully. Percutaneous resurrection of mummy vascular access sites for hemodialysis is technically feasible with high clinical success rates. In selected patients, resurrection of mummy access sites provides long-discarded access sites one more chance to be used for hemodialysis in an effort to preserve potential extremity sites for future access-site placement and to prevent long-term catheter indwelling.
目前的研究回顾性评估了慢性血栓形成和长期废弃的血液透析血管通路部位的血管腔内再通是否可行。报告了技术和临床成功率、干预后的一期和二期通畅率以及并发症。在 1 年期间,我们共对 881 例患者的 924 例因功能障碍和/或血液透析血管通路部位和永久性导管失败而进行的干预进行了回顾性评估。对于血管通路部位问题被认为无法治疗或治疗风险高且有废弃通路部位风险的患者,我们试图对慢性闭塞和长期废弃(木乃伊)血管通路部位进行再通(复活)。我们试图复活总共 18 个(平均年龄 46.6 ± 38.7 个月;范围 5-144)在 15 名患者(8 名女性和 7 名男性;平均年龄 66.2 ± 11.5 岁;年龄范围 50-85 岁)中废弃的血管通路部位,总体技术成功率为 77.8%。在 3 个瘘管和 1 个直移植物中出现复活失败。复活后 2 个月的临床成功率为 100%。在 14 个复活的血管通路部位中,5 个瘘管需要进行 6 次球囊辅助成熟术;通路部位成熟后,共进行了 22 次干预以维持通路部位通畅。成功复活手术的平均通过时间为 146.6 ± 34.3 分钟(范围 74-193)。成熟后一期通畅率分别为 30 天 71.4 ± 12.1%、60 天 57.1 ± 13.2%、90 天 28.6 ± 13.4%和 180 天 19 ± 11.8%。成熟后二期通畅率分别为 30、60 和 90 天 100%和 180 天 81.8 ± 11.6%。有 2 例严重并发症,在 2 个木乃伊血管通路部位进行球囊扩张时发生大量静脉破裂;在这两种情况下,长时间球囊充气均未能止血,但成功进行了经皮 N-丁基氰基丙烯酸酯胶密封。经皮复活用于血液透析的木乃伊血管通路部位在技术上是可行的,具有较高的临床成功率。在选择的患者中,复活木乃伊通路部位为长期废弃的通路部位再次提供了一次用于血液透析的机会,以努力保留潜在的肢体部位用于未来的通路部位放置,并防止长期留置导管。